craft-sa-dev Home  

PMC:1584416 / 4339-4757 JSONTXT 5 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T999 0-166 sentence denotes A related disorder with the cancer predisposition of XP combined with the neurodevelopmental complications of CS (XPCS), although rare, has also been described [18].
T1000 1-2 DT denotes A
T1002 3-10 JJ denotes related
T1001 11-19 NN denotes disorder
T1004 20-24 IN denotes with
T1005 25-28 DT denotes the
T1007 29-35 NN denotes cancer
T1006 36-50 NN denotes predisposition
T1008 51-53 IN denotes of
T1009 54-56 NN denotes XP
T1010 57-65 VBN denotes combined
T1011 66-70 IN denotes with
T1012 71-74 DT denotes the
T1014 75-93 JJ denotes neurodevelopmental
T1013 94-107 NNS denotes complications
T1015 108-110 IN denotes of
T1016 111-113 NN denotes CS
T1017 114-115 -LRB- denotes (
T1018 115-119 NN denotes XPCS
T1019 119-120 -RRB- denotes )
T1020 120-122 , denotes ,
T1021 122-130 IN denotes although
T1022 131-135 JJ denotes rare
T1023 135-137 , denotes ,
T1024 137-140 VBZ denotes has
T1025 141-145 RB denotes also
T1026 146-150 VBN denotes been
T1003 151-160 VBN denotes described
T1027 161-162 -LRB- denotes [
T1028 162-164 CD denotes 18
T1029 164-165 -RRB- denotes ]
T1030 165-166 . denotes .
T1031 166-348 sentence denotes Many XPD mutations are associated with an exclusive disease phenotype (e.g., XPDR722W with TTD and XPDR683W with XP) and are thus viewed as causative of the corresponding syndromes.
T1032 167-171 JJ denotes Many
T1034 172-175 NN denotes XPD
T1033 176-185 NNS denotes mutations
T1036 186-189 VBP denotes are
T1035 190-200 VBN denotes associated
T1037 201-205 IN denotes with
T1038 206-208 DT denotes an
T1040 209-218 JJ denotes exclusive
T1041 219-226 NN denotes disease
T1039 227-236 NN denotes phenotype
T1042 237-238 -LRB- denotes (
T1044 238-242 FW denotes e.g.
T1045 242-244 , denotes ,
T1043 244-252 NN denotes XPDR722W
T1046 253-257 IN denotes with
T1047 258-261 NN denotes TTD
T1048 262-265 CC denotes and
T1049 266-274 NN denotes XPDR683W
T1050 275-279 IN denotes with
T1051 280-282 NN denotes XP
T1052 282-283 -RRB- denotes )
T1053 284-287 CC denotes and
T1054 288-291 VBP denotes are
T1056 292-296 RB denotes thus
T1055 297-303 VBN denotes viewed
T1057 304-306 IN denotes as
T1058 307-316 JJ denotes causative
T1059 317-319 IN denotes of
T1060 320-323 DT denotes the
T1062 324-337 VBG denotes corresponding
T1061 338-347 NNS denotes syndromes
T1063 347-348 . denotes .
T1065 349-356 NNS denotes Alleles
T1067 357-360 RB denotes not
T1068 361-371 VBN denotes associated
T1069 372-383 RB denotes exclusively
T1070 384-388 IN denotes with
T1071 389-392 CD denotes one
T1072 393-401 NN denotes disorder
T1073 402-405 VBP denotes are
T1066 406-416 VBN denotes considered
T1074 417-418 `` denotes “
R657 T1000 T1001 det A,disorder
R658 T1001 T1003 nsubjpass disorder,described
R659 T1002 T1001 amod related,disorder
R660 T1004 T1001 prep with,disorder
R661 T1005 T1006 det the,predisposition
R662 T1006 T1004 pobj predisposition,with
R663 T1007 T1006 compound cancer,predisposition
R664 T1008 T1006 prep of,predisposition
R665 T1009 T1008 pobj XP,of
R666 T1010 T1006 acl combined,predisposition
R667 T1011 T1010 prep with,combined
R668 T1012 T1013 det the,complications
R669 T1013 T1011 pobj complications,with
R670 T1014 T1013 amod neurodevelopmental,complications
R671 T1015 T1013 prep of,complications
R672 T1016 T1015 pobj CS,of
R673 T1017 T1018 punct (,XPCS
R674 T1018 T1016 parataxis XPCS,CS
R675 T1019 T1018 punct ),XPCS
R676 T1020 T1003 punct ", ",described
R677 T1021 T1022 mark although,rare
R678 T1022 T1003 advcl rare,described
R679 T1023 T1003 punct ", ",described
R680 T1024 T1003 aux has,described
R681 T1025 T1003 advmod also,described
R682 T1026 T1003 auxpass been,described
R683 T1027 T1028 punct [,18
R684 T1028 T1003 parataxis 18,described
R685 T1029 T1028 punct ],18
R686 T1030 T1003 punct .,described
R687 T1032 T1033 amod Many,mutations
R688 T1033 T1035 nsubjpass mutations,associated
R689 T1034 T1033 compound XPD,mutations
R690 T1036 T1035 auxpass are,associated
R691 T1037 T1035 prep with,associated
R692 T1038 T1039 det an,phenotype
R693 T1039 T1037 pobj phenotype,with
R694 T1040 T1039 amod exclusive,phenotype
R695 T1041 T1039 compound disease,phenotype
R696 T1042 T1043 punct (,XPDR722W
R697 T1043 T1039 parataxis XPDR722W,phenotype
R698 T1044 T1043 advmod e.g.,XPDR722W
R699 T1045 T1043 punct ", ",XPDR722W
R700 T1046 T1043 prep with,XPDR722W
R701 T1047 T1046 pobj TTD,with
R702 T1048 T1043 cc and,XPDR722W
R703 T1049 T1043 conj XPDR683W,XPDR722W
R704 T1050 T1049 prep with,XPDR683W
R705 T1051 T1050 pobj XP,with
R706 T1052 T1043 punct ),XPDR722W
R707 T1053 T1035 cc and,associated
R708 T1054 T1055 auxpass are,viewed
R709 T1055 T1035 conj viewed,associated
R710 T1056 T1055 advmod thus,viewed
R711 T1057 T1055 prep as,viewed
R712 T1058 T1057 pobj causative,as
R713 T1059 T1058 prep of,causative
R714 T1060 T1061 det the,syndromes
R715 T1061 T1059 pobj syndromes,of
R716 T1062 T1061 amod corresponding,syndromes
R717 T1063 T1035 punct .,associated
R718 T1065 T1066 nsubjpass Alleles,considered
R719 T1067 T1068 neg not,associated
R720 T1068 T1065 acl associated,Alleles
R721 T1069 T1068 advmod exclusively,associated
R722 T1070 T1068 prep with,associated
R723 T1071 T1072 nummod one,disorder
R724 T1072 T1070 pobj disorder,with
R725 T1073 T1066 auxpass are,considered